Blood transfusions lead to improved outcomes in mouse models of ischemic stroke. Researchers believe the findings could be used for the treatment of stroke in humans.
A new online tool can help individuals determine their risk of ischemic stroke. Preliminary findings from those who used the tool report a strong association between metabolic syndrome and ischemic stroke risk was in white women.
DHA treatment reduced the size of the damaged brain area and initiated a repair mechanism in animal models of stroke. DHA affected the levels of MANF and TREM2, two proteins critical for communication between brain cells.
Coronavirus infection can lead to an array of neurological complications, including delirium, stroke, and a rare, often fatal neuroinflammatory condition called ADEM. The neurological complications did not always correlate with the severity of respiratory symptoms. In some patients, brain inflammation was likely caused by an immune response to COVID-19, suggesting the neurological damage may be a result of immune system activation rather than the virus itself.
A new study highlights the most common neurological and psychological complications that arise as a result of coronavirus infection. The most common brain complication was stroke, reported in 77 of 125 patients studied. Of those, 57 patients had a stroke caused by a blood clot in the brain. Behavioral changes, confusion, and altered mental state were also reported in a significant number of patients. Depression and anxiety were also commonly reported. Ten patients developed psychosis as a result of COVID-19, and six developed a dementia-like syndrome.
Roughly 50% of patients hospitalized for COVID-19 experience neurological symptoms including headaches, dizziness, smell and taste disorders, and stroke, a new study reports. Coronavirus may affect the entire nervous system, including the brain, spinal cord, and muscles. Neurological symptoms of COVID-19 may appear before the fever and cough commonly associated with infection.
Recovered stroke patients who suffer from sleep-wake disruptions are more likely to experience another stroke, researchers report.
A new case study reveals a link between COVID-19 and clotting in blood vessels in the brain that results in an increased risk of ischemic stroke. Five of the six cases included in the study suffered an ischemic stroke within 8-24 days of the onset of coronavirus symptoms. Early use of anticoagulants might help reduce the risk of blood clotting and stroke in patients with COVID-19.
An aerosolized version of tissue plasminogen activator (tPA), a clot-busing drug commonly used for the treatment of stroke patients, could target blood clots that form as a result of severe coronavirus infection.
Between 2000 and 2015, the rate of ischemic strokes decreased by 43%, with the risk of death falling by 24%. Researchers attribute the declines to improved treatment options.
Eating a vegetarian diet rich in nuts, soy, and vegetables may have a neuroprotective advantage when it comes to reducing stroke risk.
Transcranial magnetic stimulation (TMS) shows promise in diminishing the effects of early dementia and proves a safe and effective method for treating acute migraine and PPA.
